Stockreport

Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements [Yahoo! Finance]

NLS Pharmaceutics Ltd. - Common Shares  (NLSP) 
PDF biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous system disorders, announced today that it received notice from the Nasda [Read more]